You have 9 free searches left this month | for more free features.

Dysentery, Bacillary

Showing 1 - 25 of 48

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Shigellosis, Bacillary Dysentery Trial in Leiden (2.5 µg InvaplexAR-Detox, 10 µg InvaplexAR-Detox, 0.1 µg of dmLT)

Not yet recruiting
  • Shigellosis
  • Bacillary Dysentery
  • 2.5 μg InvaplexAR-Detox
  • +3 more
  • Leiden, Netherlands
    Leiden University Medical Center
Jul 26, 2023

Shigellosis Trial in Dhaka (Tebipenem Pivoxil, Azithromycin, Ceftriaxon)

Recruiting
  • Shigellosis
  • Tebipenem Pivoxil
  • +2 more
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Disease Research, Bangladesh
Jan 18, 2023

Shigellosis Trial in Kilifi (Shigella sonnei 53G, Ciprofloxacin 500 mg)

Not yet recruiting
  • Shigellosis
  • Shigella sonnei 53G
  • Ciprofloxacin 500 mg
  • Kilifi, Kenya
    KEMRI-Wellcome Trust Research Programme
Jul 17, 2023

Dysentery, Dysentery, Bacillary Trial in Quanzhou (S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine, Haemophilus b Conjugate

Completed
  • Dysentery
  • Dysentery, Bacillary
  • S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine
  • Haemophilus b Conjugate Vaccine
  • Quanzhou, Guangxi, China
    Quanzhou Center for Disease Control and Prevention
Dec 28, 2021

Immunisation, Shigella Infection Trial in Cincinnati (Placebo, Shigella sonnei strain 53G, WRSs2)

Recruiting
  • Immunisation
  • Shigella Infection
  • Placebo
  • +2 more
  • Decatur, Georgia
  • +1 more
Feb 2, 2023

Support of Clinical Evaluation ofOral Shigella Vaccine

Completed
  • Diarrhea
  • Diarrhea Infectious
  • no intervention
  • Ouagadougou, Burkina Faso
  • +2 more
Jul 19, 2022

Shigella Infection, Enterotoxigenic Escherichia Coli Infection Trial in Baltimore (strain CVD 1208S-122, Placebo)

Not yet recruiting
  • Shigella Infection
  • Enterotoxigenic Escherichia Coli Infection
  • strain CVD 1208S-122
  • Placebo
  • Baltimore, Maryland
    University of Maryland, Baltimore, University of Maryland School
Jul 26, 2022

Shigellosis Trial in Kericho, Kilifi (Shigella 4V, MenACWY, Rabies)

Completed
  • Shigellosis
  • Shigella 4V
  • +4 more
  • Kericho, Kenya
  • +1 more
Dec 7, 2022

Shigella Trial in Baltimore (SF2a-TT15 Shigella Vaccine, Placebo, S. flexneri 2a strain 2457T Challenge Agent)

Recruiting
  • Shigella
  • SF2a-TT15 Shigella Vaccine
  • +2 more
  • Baltimore, Maryland
    University of Maryland, Baltimore, Center for Vaccine Developmen
May 5, 2022

Shigellosis Trial in Baltimore (S. sonnei 53G, S. flexneri 2a 2457T)

Recruiting
  • Shigellosis
  • S. sonnei 53G
  • S. flexneri 2a 2457T
  • Baltimore, Maryland
    Center for Immunization Research (CIR) at Johns Hopkins School o
Dec 15, 2021

Shigellosis, Bacillary Dysentery Trial in Silver Spring (Shigella flexneri 2a InvaplexAR)

Completed
  • Shigellosis
  • Bacillary Dysentery
  • Shigella flexneri 2a InvaplexAR
  • Silver Spring, Maryland
    Walter Reed Army Institute of Research, Clinical Trials Center
Feb 10, 2021

Dysentery, Shigellosis Trial in China (S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine, Placebo)

Recruiting
  • Dysentery
  • Shigellosis
  • S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine
  • Placebo
  • Hezhou, Guangxi, China
  • +8 more
Jan 6, 2022

Enterics for Global Health (EFGH)

Recruiting
  • Shigella
  • +2 more
    • Dhaka, Bangladesh
    • +32 more
    Sep 18, 2023

    Shigella Trial in Baltimore (CVD 1208S, a Shigella flexneri 2a live, oral vaccine, Placebo)

    Terminated
    • Shigella
    • CVD 1208S, a Shigella flexneri 2a live, oral vaccine
    • Placebo
    • Baltimore, Maryland
      University of Maryland, Baltimore Center for Vaccine Development
    Apr 27, 2021

    Shigellosis Trial in Baltimore (Flexyn2a, Placebo)

    Completed
    • Shigellosis
    • Flexyn2a
    • Placebo
    • Baltimore, Maryland
      Johns Hopkins Bloomberg School of Public Health, CIR
    Jan 7, 2021

    Shigella Trial in Baltimore (CVD 1208S, a Shigella flexneri 2a live, oral vaccine, Placebo)

    Completed
    • Shigella
    • CVD 1208S, a Shigella flexneri 2a live, oral vaccine
    • Placebo
    • Baltimore, Maryland
    • +1 more
    Apr 27, 2021

    Shigella Trial in Baltimore (CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a)

    Terminated
    • Shigella
    • CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a
    • Baltimore, Maryland
    • +1 more
    Apr 27, 2021

    Shigellosis Trial in Baltimore (Vaccine: 2.6±0.8 x 10^8 vp/mL, 1 dose, Vaccine: 2.6±0.8 x 10^9 vp/mL, 3 doses, Vaccine: 2.6±0.8

    Completed
    • Shigellosis
    • Vaccine: 2.6±0.8 x 10^8 vp/mL, 1 dose
    • +4 more
    • Baltimore, Maryland
    • +1 more
    Aug 10, 2021

    Dysentery, Bacillary Trial in Cincinnati (S.sonnei vaccine, Placebo, S. sonnei 53G challenge strain)

    Completed
    • Dysentery, Bacillary
    • S.sonnei vaccine
    • +2 more
    • Cincinnati, Ohio
      GSK Investigational Site
    Jul 16, 2020

    Weight Gain, Anemia, Iron Deficiency, Birth Weight Trial in Mataram (Egg intervention)

    Recruiting
    • Weight Gain
    • +16 more
    • Egg intervention
    • Mataram, West Nusa Tenggara, Indonesia
      Aikmel, Sakra, and Sikur Subdistrict
    Mar 17, 2021

    Immunogenicity, Shigellosis Trial in Petach Tikva (Shigella Sonnei O-SPC/rBRU)

    Completed
    • Immunogenicity
    • Shigellosis
    • Shigella Sonnei O-SPC/rBRU
    • Petach Tikva, Israel
      Schneider Children's Hospital
    Dec 13, 2019

    Dysentery, Bacillary Trial in Paris (GVGH Shigella sonnei 1790GAHB vaccine)

    Completed
    • Dysentery, Bacillary
    • GVGH Shigella sonnei 1790GAHB vaccine
    • Paris, France
      GSK Investigational Site
    Jun 13, 2019

    Healthy Trial in Cincinnati (Shigella sonnei 53G)

    Completed
    • Healthy
    • Shigella sonnei 53G
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Feb 21, 2019

    Multidrug Resistant Shigella Infection in Bangladesh

    Unknown status
    • Diarrhea
    • Shigella
      • Dhaka, Bangladesh
        International Centre for Diarrhoeal Disease Research
      Jan 25, 2019

      Dysentery, Dysentery, Bacillary Trial in Yizhou (S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine)

      Completed
      • Dysentery
      • Dysentery, Bacillary
      • S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine
      • Yizhou, Guangxi, China
        Yizhou Center for Disease Control and Prevention
      Oct 15, 2018